Trial Profile
Prospective study of effect of dutasteride administration and correlations between clinical parameters and change of urinary nerve growth factor in patients with benign prostatic enlargement
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics; Therapeutic Use
- 11 Dec 2015 New trial record